Arovella Therapeutics Ltd - Asset Resilience Ratio

Latest as of December 2025: 95.65%

Arovella Therapeutics Ltd (ALA) has an Asset Resilience Ratio of 95.65% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Arovella Therapeutics Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

AU$19.37 Million

≈ $13.70 Million USD Cash + Short-term Investments

Total Assets

AU$20.25 Million

≈ $14.33 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2025)

This chart shows how Arovella Therapeutics Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Arovella Therapeutics Ltd (ALA) total assets.

Liquid Assets Composition Over Time

This chart breaks down Arovella Therapeutics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read ALA total debt and obligations for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$19.37 Million	95.65%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$19.37 Million	95.65%

Asset Resilience Insights

Very High Liquidity: Arovella Therapeutics Ltd maintains exceptional liquid asset reserves at 95.65% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Arovella Therapeutics Ltd Industry Peers by Asset Resilience Ratio

Compare Arovella Therapeutics Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Galapagos N.V. AS:GLPG	Biotechnology	86.45%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Sinopep-Allsino Biopharmaceutical Co. Ltd. A SHG:688076	Biotechnology	0.91%

Annual Asset Resilience Ratio for Arovella Therapeutics Ltd (2006–2025)

The table below shows the annual Asset Resilience Ratio data for Arovella Therapeutics Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	96.65%	AU$20.88 Million ≈ $14.77 Million	AU$21.60 Million ≈ $15.28 Million	+0.95pp
2024-06-30	95.71%	AU$12.71 Million ≈ $9.00 Million	AU$13.28 Million ≈ $9.40 Million	+1.11pp
2023-06-30	94.60%	AU$5.18 Million ≈ $3.66 Million	AU$5.47 Million ≈ $3.87 Million	+28.70pp
2022-06-30	65.90%	AU$6.07 Million ≈ $4.30 Million	AU$9.21 Million ≈ $6.52 Million	+3.05pp
2021-06-30	62.85%	AU$6.72 Million ≈ $4.75 Million	AU$10.69 Million ≈ $7.56 Million	+48.28pp
2020-06-30	14.57%	AU$977.47K ≈ $691.62K	AU$6.71 Million ≈ $4.75 Million	-11.97pp
2019-06-30	26.54%	AU$4.31 Million ≈ $3.05 Million	AU$16.25 Million ≈ $11.50 Million	+25.95pp
2018-06-30	0.59%	AU$98.13K ≈ $69.43K	AU$16.64 Million ≈ $11.78 Million	-8.25pp
2017-06-30	8.84%	AU$1.77 Million ≈ $1.25 Million	AU$20.02 Million ≈ $14.16 Million	+8.13pp
2009-06-30	0.71%	AU$118.52K ≈ $83.86K	AU$16.61 Million ≈ $11.75 Million	-0.01pp
2008-06-30	0.73%	AU$116.62K ≈ $82.52K	AU$16.06 Million ≈ $11.37 Million	-8.25pp
2007-06-30	8.98%	AU$1.89 Million ≈ $1.33 Million	AU$21.00 Million ≈ $14.86 Million	+1.64pp
2006-06-30	7.34%	AU$1.22 Million ≈ $863.57K	AU$16.63 Million ≈ $11.77 Million	--

pp = percentage points

About Arovella Therapeutics Ltd

AU:ALA Australia Biotechnology

Market Cap

$49.61 Million

AU$70.11 Million AUD

Market Cap Rank

#22011 Global

#774 in Australia

Share Price

AU$0.06

Change (1 day)

-1.69%

52-Week Range

AU$0.06 - AU$0.10

All Time High

AU$0.57